Research Topics
| Diana PaleacuSummaryAffiliation: Tel Aviv University Country: Israel Publications
| Collaborators
|
Detail Information
Publications
Effect of dopamine agonists on fatigue and somnolence in Parkinson's diseaseDaniel Oved
Department of Neurology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
Mov Disord 21:1257-61. 2006..63 vs. 11.7 +/- 5.16; P < 0.05). Fatigue is prevalent in patients with PD but is not influenced by dopamine agonists. Somnolence cannot be attributed to the increase in fatigability and apparently involves a different mechanism...- Effects of pharmacological therapy on gait and cognitive function in depressed patientsDiana Paleacu
Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
Clin Neuropharmacol 30:63-71. 2007..To investigate the relationship among affective status, cognitive function, and gait in depressed patients and to evaluate the effects of treatment of depression on gait and cognitive function... - Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled studyD Paleacu
Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, Israel
Int J Geriatr Psychiatry 23:393-400. 2008..Quetiapine is an atypical antipsychotic agent that warrants further investigation... - Olanzapine in Huntington's diseaseD Paleacu
Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Keren Kayemet, Bat Yam, Sackler School of Medicine, Tel Aviv University, Israel
Acta Neurol Scand 105:441-4. 2002..To study the effect of olanzapine (OL) in Huntington's disease (HD) patients... - Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's diseaseDiana Paleacu
Neurological Service and Memory Clinic, Abarbanel Mental Health Center, Sackler School of Medicine, Tel Aviv University, Bat Yam, Israel
Clin Neuropharmacol 25:313-7. 2002..Acetylcholinesterase inhibitors should be considered for the treatment of BPSD before neuroleptic treatment is instituted in AD patients with low levels of irritability and agitation... - Tetrabenazine treatment in movement disordersD Paleacu
Neurology Service and Memory Clinic, Abarbanel Mental Health Center, Bat Yam, affiliated to the Sackler School of Medicine, Tel Aviv University, Israel
Clin Neuropharmacol 27:230-3. 2004..4 +/- 21.3 months. The report concludes that TBZ is a moderately effective treatment of a large variety of hyperkinetic movement disorders, with excellent effects in a subgroup with chorea and facial dystonia/dyskinesias... - Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatientsYoram Barak
Abarbanel Mental Health Center, Bat Yam, Israel
Am J Geriatr Psychiatry 15:354-6. 2007..To evaluate the rate of adverse medical outcomes for elderly exposed to antipsychotic treatment... 
Quetiapine augmentation of antidepressant treatment in elderly patients suffering from depressive symptoms: a retrospective chart reviewShelly Tadger
Abarbanel Mental Health Center, affiliated with the Sackler School of Medicine, Tel Aviv University, 15 KKL Street, Bat Yam, 59100 Israel
Arch Gerontol Geriatr 53:104-5. 2011..Further prospective studies need be carried out to support our observation...- Quetiapine for elderly non-responsive schizophrenia patientsDoron Mazeh
Abarbanel Mental Health Center, Tel Aviv University, Israel
Psychiatry Res 157:265-7. 2008..Four patients discontinued treatment due to clinical exacerbation or sedation. There was no increase in abnormal movements or body weight... - Narcolepsy and psychotic states--a case reportYuval Melamed
Lev Hasharon Mental Health Center, Netanya, Israel
Isr J Psychiatry Relat Sci 46:70-3. 2009..Multidisciplinary cooperation of neurologists and psychiatrists enabled this therapy to be administered for the patient's benefit... - Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled studyD Mazeh
Psychogeriatric Ward, Abarbanel Mental Health Center, Bat Yam and the Sackler School of Medicine, Tel Aviv University, Israel
Int Psychogeriatr 18:429-36. 2006..Donepezil inhibits cholinesterase, thus enhancing cholinergic neurotransmission. We tested the efficacy of donepezil in elderly patients with chronic schizophrenia and severe cognitive impairment... - Association between family history of dementia and hallucinations in Parkinson diseaseDiana Paleacu
Neurology Service and Memory Clinic, Yehuda Abarbanel Mental Health Center and Sackler Faculty of Medicine, Tel-Aviv University, Israel
Neurology 64:1712-5. 2005..0001) and positive family history of dementia (p = 0.0005). CONCLUSION: Family history of dementia and lower Mini-Mental State Examination scores are risk factors for hallucinations in Parkinson disease... - Risk factors for dementia, depression and psychosis in long-standing Parkinson's diseaseN Giladi
Department of Neurology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel
J Neural Transm 107:59-71. 2000..To study the relationships between clinical features of Parkinson's disease (PD) and the development of dementia, depression or psychosis in patients with long-standing disease... - Donepezil for the treatment of a schizophrenia patient with frontal lobotomyDoron Mazeh
J Clin Psychopharmacol 23:522. 2003